Skip to main content
Top
Published in: BMC Nephrology 1/2006

Open Access 01-12-2006 | Case report

Gitelman-like syndrome after cisplatin therapy: a case report and literature review

Authors: Kessarin Panichpisal, Freddy Angulo-Pernett, Sharmila Selhi, Kenneth M Nugent

Published in: BMC Nephrology | Issue 1/2006

Login to get access

Abstract

Background

Cisplatin is a well-known nephrotoxic antineoplastic drug. Chronic hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria is one of the rare complications associated with its use.

Case presentation

A 42- year-old woman presented with a 20 year-history of hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria after cisplatin-based chemotherapy for ovarian cancer. This patient has had chronic muscle aches and fatigue and has had episodic seizure-like activity and periodic paralysis. Only thirteen other patients with similar electrolyte abnormalities have been described in the literature. This case has the longest follow-up.

Conclusion

Cisplatin can cause permanent nephrotoxicity, including Gitelman-like syndrome. This drug should be considered among the possible causes of chronic unexplained electrolyte disorders.
Literature
1.
go back to reference Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol. 2003, 23: 460-464. 10.1016/S0270-9295(03)00089-5.CrossRefPubMed Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol. 2003, 23: 460-464. 10.1016/S0270-9295(03)00089-5.CrossRefPubMed
2.
go back to reference Knoers NV, de Jong JC, Meij IC, Van Den Heuvel LP, Bindels RJ: Genetic renal disorders with hypomagnesemia and hypocalciuria. J Nephrol. 2003, 16: 293-296.PubMed Knoers NV, de Jong JC, Meij IC, Van Den Heuvel LP, Bindels RJ: Genetic renal disorders with hypomagnesemia and hypocalciuria. J Nephrol. 2003, 16: 293-296.PubMed
3.
go back to reference Mavichak V, Coppin CM, Wong NL, Dirks JH, Walker V, Sutton RA: Renal magnesium wasting and hypocalciuria in chronic cis-platinum nephropathy in man. Clin Sci. 1988, 75: 203-207.CrossRefPubMed Mavichak V, Coppin CM, Wong NL, Dirks JH, Walker V, Sutton RA: Renal magnesium wasting and hypocalciuria in chronic cis-platinum nephropathy in man. Clin Sci. 1988, 75: 203-207.CrossRefPubMed
4.
go back to reference Bianchetti MG, Kanaka C, Ridolfi-Luthy A, Wagner HP, Hirt A, Paunier L, Peheim E, Oetliker OH: Chronic renal magnesium loss, hypocalciuria and mild hypokalemic alkalosis after cisplatin. Pediatr Nephrol. 1990, 4: 219-222. 10.1007/BF00857658.CrossRefPubMed Bianchetti MG, Kanaka C, Ridolfi-Luthy A, Wagner HP, Hirt A, Paunier L, Peheim E, Oetliker OH: Chronic renal magnesium loss, hypocalciuria and mild hypokalemic alkalosis after cisplatin. Pediatr Nephrol. 1990, 4: 219-222. 10.1007/BF00857658.CrossRefPubMed
5.
go back to reference Bianchetti MG, Kanaka C, Ridolfi-Luthy A, Hirt A, Wagner HP, Oetliker OH: Persisting renotubular sequelaeafter cisplatin in children and adolescents. Am J Nephrol. 1991, 11: 127-130.CrossRefPubMed Bianchetti MG, Kanaka C, Ridolfi-Luthy A, Hirt A, Wagner HP, Oetliker OH: Persisting renotubular sequelaeafter cisplatin in children and adolescents. Am J Nephrol. 1991, 11: 127-130.CrossRefPubMed
6.
go back to reference Shaer AJ: Inherited Primary Renal Tubular HypokalemicAlkalosis: A Review of Gitelman and Bartter Syndromes. Am J Med Sci. 2001, 322: 316-332. 10.1097/00000441-200112000-00004.CrossRefPubMed Shaer AJ: Inherited Primary Renal Tubular HypokalemicAlkalosis: A Review of Gitelman and Bartter Syndromes. Am J Med Sci. 2001, 322: 316-332. 10.1097/00000441-200112000-00004.CrossRefPubMed
7.
go back to reference Mayan H, Gurevitz O, Farfei Z: Successful treatment by cyclooxygenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman'syndrome. Clin Nephro. 2002, 58: 73-76.CrossRef Mayan H, Gurevitz O, Farfei Z: Successful treatment by cyclooxygenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman'syndrome. Clin Nephro. 2002, 58: 73-76.CrossRef
Metadata
Title
Gitelman-like syndrome after cisplatin therapy: a case report and literature review
Authors
Kessarin Panichpisal
Freddy Angulo-Pernett
Sharmila Selhi
Kenneth M Nugent
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2006
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-7-10

Other articles of this Issue 1/2006

BMC Nephrology 1/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.